{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T14:04:39Z","timestamp":1791641079898,"version":"4.3.4"},"reference-count":45,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T00:00:00Z","timestamp":1625616000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p>As one of the clinical triad in Huntington's disease (HD), cognitive impairment has not been widely accepted as a disease stage indicator in HD literature. This work aims to study cognitive impairment thoroughly for prodromal HD individuals with the data from a 12-year observational study to determine whether Mild Cognitive Impairment (MCI) in HD gene-mutation carriers is a defensible indicator of early disease. Prodromal HD gene-mutation carriers evaluated annually at one of 32 worldwide sites from September 2002 to April 2014 were evaluated for MCI in six cognitive domains. Linear mixed-effects models were used to determine age-, education-, and retest-adjusted cut-off values in cognitive assessment for MCI, and then the concurrent and predictive validity of MCI was assessed. Accelerated failure time (AFT) models were used to determine the timing of MCI (single-, two-, and multiple-domain), and dementia, which was defined as MCI plus functional loss. Seven hundred and sixty-eight prodromal HD participants had completed all six cognitive tasks, had MRI, and underwent longitudinal assessments. Over half (i.e., 54%) of the participants had MCI at study entry, and half of these had single-domain MCI. Compared to participants with intact cognitive performances, prodromal HD with MCI had higher genetic burden, worsened motor impairment, greater brain atrophy, and a higher likelihood of estimated HD onset. Prospective longitudinal study of those without MCI at baseline showed that 48% had MCI in subsequent visits and data visualization suggested that single-domain MCI, two-domain MCI, and dementia represent appropriate cognitive impairment staging for HD gene-mutation carriers. Findings suggest that MCI represents an early landmark of HD and may be a sensitive enrichment variable or endpoint for prodromal clinical trials of disease modifying therapeutics.<\/jats:p>","DOI":"10.3389\/fneur.2021.678652","type":"journal-article","created":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T05:13:04Z","timestamp":1625634784000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":16,"title":["Mild Cognitive Impairment as an Early Landmark in Huntington's Disease"],"prefix":"10.3389","volume":"12","author":[{"given":"Ying","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carissa R.","family":"Gehl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey D.","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent A.","family":"Magnotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Sewell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Shannon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane S.","family":"Paulsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,7,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1136\/jnnp.2007.128728","article-title":"Detection of Huntington's disease decades before diagnosis: the Predict-HD study","volume":"79","author":"Paulsen","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B2","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1007\/s11910-011-0215-x","article-title":"Cognitive impairment in Huntington disease: diagnosis and treatment","volume":"11","author":"Paulsen","year":"2011","journal-title":"Curr Neurol Neurosci Rep."},{"key":"B3","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1136\/jnnp-2011-301940","article-title":"Evaluation of longitudinal 12 and 24 month cognitive outcomes in premanifest and early Huntington's disease","volume":"83","author":"Stout","year":"2012","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1136\/jnnp-2013-305114","article-title":"Cognitive decline in prodromal Huntington Disease: implications for clinical trials","volume":"84","author":"Paulsen","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B5","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1212\/WNL.0b013e3181eccfa2","article-title":"Mild cognitive impairment in prediagnosed Huntington disease","volume":"75","author":"Duff","year":"2010","journal-title":"Neurology."},{"key":"B6","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1056\/NEJMoa1900907","article-title":"Targeting Huntingtin expression in patients with Huntington's disease","volume":"380","author":"Tabrizi","year":"2019","journal-title":"N Engl J Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1001\/archneur.56.3.303","article-title":"Mild cognitive impairment: clinical characterization and outcome","volume":"56","author":"Petersen","year":"1999","journal-title":"Arch Neurol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1111\/j.1365-2796.2004.01380.x","article-title":"Mild cognitive impairment\u2013beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment","volume":"256","author":"Winblad","year":"2004","journal-title":"J Intern Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1212\/WNL.56.9.1133","article-title":"Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). report of the quality standards subcommittee of the American Academy of Neurology","volume":"56","author":"Petersen","year":"2001","journal-title":"Neurology."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1001\/archneur.58.12.1985","article-title":"Current concepts in mild cognitive impairment","volume":"58","author":"Petersen","year":"2001","journal-title":"Arch Neurol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1002\/mds.21453","article-title":"Defining mild cognitive impairment in Parkinson's disease","volume":"22","author":"Caviness","year":"2007","journal-title":"Mov Disord"},{"key":"B12","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s40035-017-0094-4","article-title":"Mild cognitive impairment in Parkinson's disease: a distinct clinical entity?","volume":"6","author":"Wen","year":"2017","journal-title":"Translat Neruodegen."},{"key":"B13","doi-asserted-by":"publisher","first-page":"116523","DOI":"10.1016\/j.jns.2019.116523","article-title":"Mild cognitive impairment and dementia in motor manifest Huntington's disease: classification and prevalence","volume":"408","author":"Julayanont","year":"2020","journal-title":"J Neurol Sci."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1212\/01.wnl.0000344650.95823.03","article-title":"Donepezil treatment of patients with MCI: a 48-week randomized, placebo-controlled trial","volume":"72","author":"Doody","year":"2009","journal-title":"Neurology."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1212\/WNL.0000000000003907","article-title":"Alzheimer's Disease Neuroimaging Initiative (ADNI) and Foundation for NIH (FNIH) biomarkers consortium AD MCI placebo data analysis project team. randomized controlled trials in mild cognitive impairment: sources of variability","volume":"88","author":"Petersen","year":"2017","journal-title":"Neurology."},{"key":"B16","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1055\/s-2007-971176","article-title":"Huntington's disease","volume":"27","author":"Walker","year":"2007","journal-title":"Semin Neurol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1136\/jnnp-2011-301732","article-title":"Cognitive domains that predict time to diagnosis in prodromal Huntington disease","volume":"83","author":"Harrington","year":"2012","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B18","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1037\/h0054651","article-title":"Studies of interference in serial verbal reactions","volume":"18","author":"Stroop","year":"1935","journal-title":"J Exp Psychol."},{"key":"B19","volume-title":"The Psychological Corporation","author":"Scale","year":"1997"},{"key":"B20","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1037\/a0018905","article-title":"Self-paced timing detects and tracks change in prodromal Huntington disease","volume":"24","author":"Rowe","year":"2010","journal-title":"Neuropsychology."},{"key":"B21","volume-title":"Symbol Digit Modalities Test","author":"Smith","year":"1991"},{"key":"B22","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1288\/00005537-198402000-00004","article-title":"University of Pennsylvania smell identification test: a rapid quantitative olfactory function test for the clinic","volume":"94","author":"Doty","year":"1984","journal-title":"Laryngoscope."},{"key":"B23","volume-title":">Hopkins Verbal Learning Test-Revised (HVLT-R) Psychological Assessment Resources","author":"Brandt","year":"2001"},{"key":"B24","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1002\/brb3.185","article-title":"Neuroanatomical correlates of cognitive functioning in prodromal Huntington disease","volume":"4","author":"Harrington","year":"2014","journal-title":"Brain Behav."},{"key":"B25","first-page":"54","article-title":"Efficient and extensible workflow: reliable whole brain segmentation for large-scale, multi-center longitudinal human MRI analysis using high performance\/throughput computing resources","volume-title":"Workshop on Clinical Image-Based Procedures","author":"Kim","year":"2015"},{"key":"B26","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3389\/fninf.2013.00029","article-title":"Robust multi-site MR data processing: iterative optimization of bias correction, tissue classification, and registration","volume":"7","author":"Kim","year":"2013","journal-title":"Front Neuroinform."},{"key":"B27","article-title":"Tissue classification of large-scale multi-site MR data using fuzzy k-nearest neighbor method","volume-title":"Medical Imaging 2016: Image Processing","author":"Ghayoor","year":"2016"},{"key":"B28","doi-asserted-by":"publisher","first-page":"242","DOI":"10.3389\/fnins.2015.00242","article-title":"Preliminary analysis using multi-atlas labeling algorithms for tracing longitudinal change","volume":"9","author":"Kim","year":"2015","journal-title":"Front Neurosci."},{"key":"B29","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1002\/ajmg.b.31232","article-title":"Indexing disease progression at study entry with individuals at-risk for Huntington disease","author":"Zhang","year":"2011","journal-title":"Am J Med Genet B Neuropsychiatry Genet"},{"key":"B30","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1002\/mds.870110204","article-title":"Unified Huntington's disease rating scale: reliability and consistency","volume":"11","year":"1996","journal-title":"Mov Disord"},{"key":"B31","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1002\/mds.20332","article-title":"Interrater agreement in the assessment of motor manifestations of Huntington's disease","volume":"20","author":"Hogarth","year":"2005","journal-title":"Mov Disord."},{"key":"B32","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1093\/arclin\/acw024","article-title":"Mild cognitive impairment in late middle age in the Wisconsin Registry for Alzheimer's Prevention Study: prevalence and characteristics using robust and standard neuropsychological normative data","volume":"31","author":"Clark","year":"2016","journal-title":"Arch Clin Neuropsychol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/mds.24893","article-title":"Diagnostic criteria for mild cognitive impairment in Parkinson's disease: movement disorder society task force guidelines","volume":"27","author":"Litvan","year":"2012","journal-title":"Mov Disord."},{"key":"B34","volume-title":"Interval-Censored Time-to-Event Data: Methods and Application","author":"Chen","year":"2013"},{"key":"B35","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1097\/01.wnn.0000152205.79033.73","article-title":"White matter volume and cognitive dysfunction in early Huntington's disease","volume":"18","author":"Beglinger","year":"2005","journal-title":"Cogn Behav Neurol."},{"key":"B36","first-page":"209","article-title":"Cognitive changes in Huntington's disease","volume":"96","author":"Paulsen","year":"2005","journal-title":"Adv Neurol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1002\/mdc3.12808","article-title":"Movement disorder society task force viewpoint: Huntington's disease diagnostic categories","volume":"6","author":"Ross","year":"2019","journal-title":"Move Disord Clin Practice."},{"key":"B38","doi-asserted-by":"publisher","first-page":"116779","DOI":"10.1016\/j.jns.2020.116779","article-title":"Mild cognitive impairment in Huntington's disease?","volume":"413","author":"Sitek","year":"2020","journal-title":"J Neurol Sci."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1212\/WNL.0000000000002100","article-title":"Spectrum of cognition short of dementia: Framingham Heart Study and Mayo Clinic Study of Aging","volume":"85","author":"Knopman","year":"2015","journal-title":"Neurology."},{"key":"B40","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.1056\/NEJMoa050151","article-title":"Vitamin E and donepezil for the treatment of mild cognitive impairment","volume":"352","author":"Petersen","year":"2005","journal-title":"N Engl J Med."},{"key":"B41","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1212\/01.wnl.0000303815.69777.26","article-title":"Safety and efficacy of galantamine in subjects with mild cognitive impairment","volume":"70","author":"Windblad","year":"2008","journal-title":"Neurology."},{"key":"B42","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/S1474-4422(07)70109-6","article-title":"Effect of rivastigmine on delay to diagnosis of Alzheimer's disease from mild cognitive impairment: the InDDEx study","volume":"6","author":"Feldman","year":"2007","journal-title":"Lancet Neurol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1038\/sj.npp.1300690","article-title":"A randomized, double-blind, study of rofecoxib in patients with mild cognitive impairment","volume":"30","author":"Thal","year":"2005","journal-title":"Neuropsychopharmacology."},{"key":"B44","volume-title":"Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition","year":"2013"},{"key":"B45","doi-asserted-by":"publisher","first-page":"125","DOI":"10.3233\/JHD-140109","article-title":"Unawareness of deficits in Huntington's disease","volume":"3","author":"Sitek","year":"2014","journal-title":"J Huntington's Dis."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.678652\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T05:13:15Z","timestamp":1625634795000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.678652\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,7]]},"references-count":45,"alternative-id":["10.3389\/fneur.2021.678652"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2021.678652","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,7]]},"article-number":"678652"}}